Physical activity, skeletal muscle β-adrenoceptor changes and oxidative metabolism in experimental chronic heart failure

Fundamental and Clinical Pharmacology

Volumn 12, Issue 3, 1998, Pages 263-269

  Michel, C ^a   Chati, Z ^a,b   Mertes, P M ^a,c   Escanye, J M ^d   Zannad, F ^a,b  

^a Pharmacology and Cardiology   (France)

^b Ctr Hospitalier Univ de Nancy   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d UNIVERSITÉ DE LORRAINE   (France)

Author keywords

31P magnetic resonance spectroscopy; Adrenergic system; Heart failure; Physical activity; Skeletal muscle; adrenergic receptors

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE PHOSPHATE; NORADRENALIN; PROPRANOLOL;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; EXERCISE; HEART FAILURE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MUSCLE METABOLISM; NONHUMAN; ORAL DRUG ADMINISTRATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; SKELETAL MUSCLE; SOLEUS MUSCLE; SYMPATHETIC TONE; TELEMETRY;

EID: 0031839408     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1998.tb00953.x     Document Type: Article

References (48)

1. Adamopoulos S, Brunotte F, Coats AJS, Lindsay D, Unnit J, Rajagopalan B, Radda G, Sleight P. Exercise training and skeletal muscle metabolism in experimental heart failure (Abstract). Eur Heart J 1991 ; 12 : 141
2. Adamopoulos S, Coats, AJS, Brunotte F, Arnolda L, Meyer T, Thompson CH, Dunn JF, Stratton J, Kemp GJ, Radda GK. Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardial 1993 ; 13 : 1101-6
3. Arnolda L, Brosnan J, Rajagopalan B, Radda GK. Skeletal muscle metabolism in heart failure in rats. Am J Physiol 1991 ; 261 : H434-42
4. Belardinelli R, Georgiou D, Scocco V, Barstow TJ, Purcaro A. Low intensity exercise training in patients with chronic heart failure. J Am Coll Cardiol 1995 ; 26 : 975-82
5. Bélichard P, Savard P, Cardinal R, Nadeau R, Gosselin H, Paradis P, Rouleau JL. Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias. J Am Coll Cardiol 1994 ; 23 : 505-13
6. 31P measurement of glucose 6 phosphate in the rat muscle after exercise. Nucl Res Med 1993 ; 30 : 347-50
7. Bristow MR, Guinsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie, K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamines sensitivity and β-adrenergic receptor density in failing human hearts. N Engl J Med 1982 ; 307 : 205-11
8. Brunotte F, Thompson CH, Adamopoulos S, Coats AJS, Unitt J, Lindsay D, Kaklamanis L, Radda GK, Rajagopalan B. Rat skeletal muscle metabolism in experimental heart failure: effects of physical training. Acta Physiol Scand 1995 ; 154 : 439-47
9. 31P NMR. Fed Proc 1986 ; 45 : 2915-20
10. Chapados RA, Gruver EJ, Ingwall JS, Marsh JD, Gwathmey JK. Chronic administration of cardiovascular drugs: altered energetics and transmembrane signaling. Am J Physiol 1992 ; 263 : H1576-86
11. Chati Z, Jeandel C, Zannad F, Bessière F, Robin B, Robert J. Aliot, E. Skeletal muscle energy phosphate metabolim abnormalities in congestive heart failure are identical to those induced by physical deconditioning (Abstract). Eur Heart J 1992 ; 13 : 433
12. Chati Z, Michel C, Escanye JM, Mertes PM, Ribuot C, Canet D, Zannad F. Skeletal muscle β-adrenoceptors and phosphate metabolism abnormalities in rats. Am J Physiol 1996 ; 271 : H1739-45
13. Chati Z, Zannad F, Jeandel C, Lherbier B, Escanye JM, Robert J, Aliot E. Physical deconditioning may be a mechanism for the skeletal muscle energy phosphate metabolism abnormalities in chronic heart failure. Am Heart J 1996 ; 131 : 560-6
14. Chati Z, Zannad F, Michel C, Lherbier B, Mertes PM, Escanye JM, Ribuot C, Robert J, Villemot JP, Aliot E. Skeletal muscle phosphate metabolism abnormalities in volume overload experimental heart failure. Am J Physiol 1994 ; 267 : H2186-92
15. 31P magnetic resonance study. Am Heart J 1994 ; 128 : 781-92
16. Chidsey CA, Braunwald E, Morrow AG. Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure. Am J Med 1965 ; 39 : 442-51
17. Ehrenström F. Determination of catechols in small volumes of plasma using ion pair reversed phase liquid chromatography. Life Sci 1988 ; 43 : 615-27
18. Frey MJ, Lanoce V, Molinoff PB, Wilson JR. Skeletal muscle beta receptors and isoproterenol stimulated vasodilatation in canine heart failure. J Appl Physiol 1989 ; 67 : 2026-31
19. Groome JR, Lent CM. Inhibitory actions of dopamine on Limulus visceral muscle involve a cyclic AMP dependant mechanism. J Comp Physiol 1992 ; 170 : 787-95
20. Ishii K, Kuwahara M, Tsubone H, Sugano S. The telemetric monitoring of heart rate, locomotor activity, and body temperature in mice and voles (Microtus arvalis) during ambient temperature changes. Lab Anim 1996 ; 30 : 7-12
21. 2-adrenoceptors in rat skeletal muscles. Biochem Pharmacol 1991 ; 42 : 1783-9
22. Kim YS, Sainz RD, Summers RJ, Molenaar P. Cimaterol induces β-adrenergic receptor density in rat skeletal muscles. J Anim Sci 1992 ; 70 : 115-22
23. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951 ; 193 : 265-75
24. Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, Wilson JR. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992 ; 85 : 1364-73
25. Marie PY, Escanye JM, Brunotte F, Robin B, Walker P, Zannad F, Robert J, Gilgenkrantz JM. Skeletal muscle metabolism in the leg during exercise in patients with congestive heart failure. Clin Sci 1990 ; 78 : 515-9
26. Martin III WH, Coggan AR, Spina RJ, Saffitz JE. Effects of fiber type and training on β-adrenoceptor density in human skeletal muscle. Am J Physiol 1989 ; 257 : E736-42
27. Massie BM, Simonini A, Sahgal P, Wells L, Dudley GA. Relation of systemic and local muscle exercise capacity to skeletal muscle characteristics in men with congestive heart failure. J Am Coll Cardiol 1996 ; 27 : 140-5
28. Michel JB, Lattion AL, Salzmann JL, Cerol ML, Philippe M, Camilleri JP, Corvol P. Hormonal and cardiac effects of angiotensin converting enzyme inhibition in rat myocardial infarction. Circ Res 1988 ; 62 : 3-14
29. Moretti-Rojas I, Ezrailson EG, Birnbaumer L, Entman ML, Garber AJ. Serotonergic and adrenergic regulation of skeletal muscle metabolism in the rat. J Biol Chem 1983 ; 254 : 12499-508
30. Munson PJ, Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980; 107 : 220-39
31. Musch TI, Zelis R. Norepinephrine response to exercise of rats with a chronic heart myocardial infarction. Med Sci Sports Exerc 1991 ; 23: 569-77
32. Ohira Y, Saito T, Wakatsuki W, Yasui T, Suetsugu K, Nakamura K, Tanaka H, Asakura T. Response of β-adrenoceptor in rat soleus to phosphorus compound levels and/or unloading. Am J Physiol 1994 ; 5 : C1257-62.
33. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996 ; 334 : 1349-55
34. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E. Myocardial infarct size and ventricular function in rats. Circ Res 1979 ; 44 : 503-12
35. Plourde G, Rousseau-Migneron S, Nadeau A. Physical training increases β-adrenergic receptor density and adrenylate cyclase activity in high oxidative skeletal muscle of diabetic rats. Metabolism 1992 ; 41 : 1331-5
36. Plourde G, Rousseau-Migneron S, Nadeau A. Effect of endurance training on β-adrenergic system in three different skeletal muscles. J Appl Physiol 1993 ; 74 : 1641-6
37. Sabbah HN, Smith FH, Sharow VG, Kono T, Lesch M, Gengo PJ, Steffen RP, Levine TB, Goldstein S. Decreased proportion of type I myofibers in skeletal muscle of dogs with chronic heart failure. Circulation 1993 ; 87 : 1729-37
38. Sullivan MJ, Hawthorne MH. Exercise intolerance in patients with chronic heart failure. Prog Cardiovasc Dis 1995 ; 38 : 1-22
39. Suter E, Hoppeler H, Claassen H, Billeter R, Aebi U, Horber F, Jaeger P, Marti B. Ultrastructural modification of human skeletal muscle tissue with 6-month moderate-intensity exercise training. Int J Sports Med 1995 ; 16 : 160-6
40. Teerlink JR, Clozel JP. Hemodynamic variability and circadian rhythm in rats with heart failure: role of locomotor activity. Am J Physiol 1993 ; 264 : H2111-8
41. Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978 ; 41 : 234-43
42. Valleres JC, Cote C, Bukowiecki L. Regulation of beta-adrenergic receptors in skeletal muscles by catecholamine in vivo. Gen Pharmacol 1979 ; 10 : 63
43. Waagstein F. Adrenergic β-blocking agents in congestive heart failure due to idiopathic dilated cardiomyopathy. Eur Heart J 1995 ; 16 (Suppl O): 128-32
44. Wasserman K. Reduced aerobic enzyme activity in skeletal muscle of patients with heart failure. A primary defect or a result of limited cardiac output. Circulation 1991 ; 84 : 1868-70
45. Wilson JR, Mancini DM. Factors contributing to the exercise limitation of heart failure. J Am Coll Cardiol 1993 ; 22 : 93A-8A
46. Wilson JR, Mancini DM, Dunkman WB. Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure. Circulation 1993 ; 87 : 470-5
47. Zannad F, Chati Z. Skeletal muscle metabolic, morphohistological, and biochemical abnormalities in congestive heart failure. Heart Failure 1994 ; 10 : 58-66
48. Zelis R, Clemson B, Baily R, Davis D. Regulation of tissue noradrenaline in the rat myocardial infarction model of chronic heart failure. Cardiovasc Res 1992 ; 26 : 933-8